2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2072
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats ; day:17 ; month:6 ; year:2016 ; pages:1-10
Psychopharmacology ; (17.6.2016), 1-10
- Urheber
-
Franke, Robert T.
- Beteiligte Personen und Organisationen
-
Tarland, Emilia
Fink, Heidrun
Pertz, Heinz H.
Brosda, Jan
SpringerLink (Online service)
- DOI
-
10.1007/s00213-016-4356-0
- URN
-
urn:nbn:de:1111-201606199592
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Franke, Robert T.
- Tarland, Emilia
- Fink, Heidrun
- Pertz, Heinz H.
- Brosda, Jan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen
High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects
Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis
Hypothermia following antipsychotic drug use
Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms
Atypical antipsychotic agents; Peas in a pod or chalk and cheese?
Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania
Retraction Note: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
Synthesis and pharmacological characterization of new histamine H1-/H4-receptor ligands derived from the atypical antipsychotic drug Clozapine
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen
High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects
Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis
Hypothermia following antipsychotic drug use
Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms
Atypical antipsychotic agents; Peas in a pod or chalk and cheese?
Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania
Retraction Note: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
Synthesis and pharmacological characterization of new histamine H1-/H4-receptor ligands derived from the atypical antipsychotic drug Clozapine
Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments
Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen
High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects
Atypical Antipsychotic Drug Olanzapine Deregulates Hepatic Lipid Metabolism and Aortic Inflammation and Aggravates Atherosclerosis
Hypothermia following antipsychotic drug use
Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms
Atypical antipsychotic agents; Peas in a pod or chalk and cheese?
Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania
Retraction Note: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis